November 9, 2026
The next breakthrough in healthcare might not be another drug. It might be a dentist.
The next breakthrough in healthcare might not be another drug. It might be a dentist.
Pharmaceutical companies invest billions developing medications for chronic diseases: diabetes, heart disease, and more. That work matters, and it continues to save and extend lives. But there is a question the industry rarely asks itself, and it is the question I want to put on the table.
The mouth is not disconnected from the body. The connections between periodontal disease, diabetes, cardiovascular health, and inflammation are well documented. Researchers keep finding more of them. And yet oral healthcare operates largely outside the traditional healthcare system: a parallel world with its own insurance, its own offices, its own vocabulary. We treat symptoms and complications while failing to integrate the mouth into overall care.
Consider what that means in practice. A patient managing diabetes sees an endocrinologist, a primary care physician, maybe a cardiologist. Almost no one on that team is looking in their mouth. Periodontal disease progresses quietly. Inflammation continues. The care team optimizes medications while an actionable contributor to the patient's health goes unaddressed, not because anyone decided to ignore it, but because the system was never built to connect the two.
Now imagine a system that integrates oral screening, preventive dental care, and timely dental intervention into chronic disease management. A system where the care team around a patient with diabetes includes a dental assessment the way it includes an eye exam. Where a hospital discharge plan includes a dental follow-up the way it includes a cardiology referral. Where the question "when did you last see a dentist?" is asked with the same routine seriousness as "when did you last have bloodwork?"
That is the system worth building. And building it does not require a new molecule.
This is a challenge to pharma, healthcare systems, hospitals, and payers to recognize oral health as essential, not an optional benefit. To be explicit about what this challenge is not: it is not an argument against pharmaceutical innovation. The industry's work on chronic disease is indispensable. The challenge is to expand what we consider innovation. Innovation is not only the new drug; it is also the integration that makes every other treatment work better. The invitation is open: bring oral health inside the tent. Partner with the people building the connective tissue. The companies that do will be treating disease more completely than the ones that don't.
The economic case points the same direction, in general terms. Poor oral health and chronic disease create costs across the system: emergency visits for problems that started small, complications that linger, care delivered in fragments instead of coordinated. Better integration could improve outcomes and potentially reduce avoidable spending. No one needs a spreadsheet to see that treating a problem early, in the right setting, by the right professional, is cheaper than treating its complications later, in the most expensive setting available. (Every system's own claims data will tell that story; the point stands without me citing figures.)
At The TeleDentists, we have built a piece of that connective tissue. Licensed dentists in all 50 states are available 24/7/365 by video, phone, mobile app, or web, often connecting within about 10 minutes, for a $64 consultation. The infrastructure matters less than the point of it: we connect oral healthcare with hospitals, medical providers, employers, payers, and patients at scale, so that the mouth finally has a seat at the table wherever care is already happening. Virtual dental care complements in-person dentistry. It is how the dental side of the house shows up inside the medical one.
I want to close with a challenge in the spirit of the next Galien Awards. The Galien Awards honor the best of biomedical innovation, and they should keep doing so. But alongside the question "what new medication should we develop?", the industry should be asking a second question: "what can we do to prevent, identify, and address the underlying contributors to disease?" That second question is where oral health lives. It is an industry challenge offered with respect. An invitation to the next generation of awardees to consider that the next breakthrough might come from integrating care, not only from inventing it.
For context on our own place in this conversation: The TeleDentists was a 2026 Prix Galien USA nominee by The Galien Foundation for Best Digital Health Solution. Nomination is recognition of the problem we work on; the work itself is what matters, and it is still ahead of us.
Oral health, particularly periodontal disease, is associated with several systemic conditions, and there is evidence that periodontal treatment can improve certain health measures, including glycemic control in people with diabetes. Oral health is an overlooked, actionable component of comprehensive healthcare, not a cure-all.
We've spent decades innovating ways to treat the body. It's time we stopped forgetting the mouth is part of it.
Let's stop treating the mouth as separate from the body. Let's make oral health part of healthcare.
The future of medicine shouldn't just be about treating disease. It should be about treating people.
Learn more or start a consultation at www.theteledentists.com. For more guidance, connect with The TeleDentists.
Virtual dental care complements rather than replaces in-person dentistry and is for screening and guidance. Clinical judgment is required for all care decisions. Anyone experiencing serious or life-threatening symptoms should seek emergency medical care immediately.